Share Email Print

Proceedings Paper

Photodynamic therapy in primary breast cancer: the first human study (Conference Presentation)
Author(s): Shramana M. Banerjee; Soha El Sheikh; Anmol Malhotra; Sandy Mosse; Sweta Parker; Norman Williams; Sandy MacRobert; Rifat Hamoudi; Stephen G. Bown; Mo R. S. Keshtgar

Paper Abstract

Primary breast cancer while increasing in incidence has been successfully treated with a combination of surgery and adjuvant therapies in the majority of patients. Novel treatments for primary breast cancer need to show additional benefits to existing treatments with equivalent or improved efficacy for niche groups. Photodynamic therapy (PDT) is a potential novel treatment and a Phase I/IIA, open label, non-randomised, single site trial of photodynamic therapy for the treatment of primary breast cancer was conducted. The primary aim was to identify the light dose required for 12 mm of tumour necrosis (or a plateau of necrosis) assessed by histopathology. Post-dose MRI correlation with histopathology findings in treated tumours and in normal breast tissue was sought. In addition adverse events were recorded and comparison of outcome made with matched controls. Results of the first human clinical trial with 12 patients with median follow-up of 39 months showed PDT was well tolerated, with no adverse effects and comparable outcome to control populations. Tumour necrosis increased with incremental increases in light dose, however some patients showed a poor response even at the highest light dose. Analysis suggests that there may be predictive factors for good and poor response. PDT in primary breast cancer requires further investigation to identify which patients would most benefit from this therapy.

Paper Details

Date Published: 14 August 2019
Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 1107055 (14 August 2019); doi: 10.1117/12.2525480
Show Author Affiliations
Shramana M. Banerjee, Royal Free London NHS Foundation Trust (United Kingdom)
Univ. College London (United Kingdom)
Soha El Sheikh, Royal Free London NHS Foundation Trust (United Kingdom)
Anmol Malhotra, Royal Free London NHS Foundation Trust (United Kingdom)
Sandy Mosse, Univ. College London (United Kingdom)
Sweta Parker, Univ. College London (United Kingdom)
Norman Williams, Univ. College London (United Kingdom)
Sandy MacRobert, Univ. College London (United Kingdom)
Rifat Hamoudi, Univ. College London (United Kingdom)
Univ. of Sharjah (United Arab Emirates)
Stephen G. Bown, Univ. College London (United Kingdom)
Mo R. S. Keshtgar, Royal Free London NHS Foundation Trust (United Kingdom)
Univ. College London (United Kingdom)

Published in SPIE Proceedings Vol. 11070:
17th International Photodynamic Association World Congress
Tayyaba Hasan, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?